Security key
44486Q103
- Security type / class
- Equity / COM
- Total 13F shares
- 9,522,696
- Total 13F value
- $69,016,600
- Share change
- +2,241,069
- Put/Call ratio
- 36%
- SEC-reported price per share
- $7.25
- Number of holders
- 58
- Value change
- +$7,310,797
- Number of buys
- 45
- Number of sells
- 12
Open additional details 1 more signal available
Report period
Q4 2021
Institutions
58
Top holders
10
HUMA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Humacyte, Inc. SEC filings
Humacyte, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 44486Q103
Recent filing periods:
Ownership snapshot
Top reported holders of HUMA - Humacyte, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FRESENIUS MEDICAL CARE HO...
Disclosed value leader
FRESENIUS MEDICAL CARE HO...
Comparable rows
0/15
Latest evidence
30 Sep 2021
3/4/5
13F
Highest disclosed value: $21,792,154
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ has the largest disclosed position value at $21.79M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRESENIUS MEDICAL CARE HOLDINGS INC /NY/'s linked filing trail.
Disclosed position value
Top 5
FRESENIUS MEDICAL CARE HOLDINGS I...
$21.79M
York Capital Management Global Ad...
$20.59M
ORBIMED ADVISORS LLC
$17.42M
Diameter Capital Partners LP
$11.08M
Monashee Investment Management LLC
$8.71M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ |
3/4/5
Former 10% Shareholder
|
—
class O/S missing
|
$21,792,154
18,312,735 shares
|
— | 26 Aug 2021 |
| York Capital Management Global Advisors, LLC |
13F
Company
|
—
class O/S missing
|
$20,590,000
2,291,397 shares
|
— | 30 Sep 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$17,415,000
1,500,000 shares
|
— | 30 Sep 2021 |
| Diameter Capital Partners LP |
13F
Company
|
—
class O/S missing
|
$11,078,000
954,138 shares
|
— | 30 Sep 2021 |
| Monashee Investment Management LLC |
13F
Company
|
—
class O/S missing
|
$8,708,000
750,000 shares
|
— | 30 Sep 2021 |
| CVI Holdings, LLC |
13F
Company
|
—
mixed-class rows
|
$6,349,000
683,850 shares
mixed-class rows
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
58
Shares
9,522,696
Rows available
58
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
31
Q4 2021 holders
58
Holder diff
27
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend